Incidence, Risk Factors, and Outcomes of BK Hemorrhagic Cystitis in Hematopoietic Stem Cell Transplantation From HLA-Matched and Haploidentical Donors With Post-Transplant Cyclophosphamide
Fecha de publicación:
Fecha Ahead of Print:
Autores de IIS La Fe
Participantes ajenos a IIS La Fe
- Montoro, J
- Gilabert, C
- Panadero, F
- Pardal, AA
- Benavente, R
- Gómez, I
- Eiris, J
- Sanz, MA
Grupos
Abstract
BK hemorrhagic cystitis (BK-HC) is a common complication following hematopoietic (PTCy) is used as graft-versus-host disease (GVHD) prophylaxis. However, comparative studies of BK-HC incidence in matched sibling donors (MSD) and unrelated donors (MUD) often include small haploidentical (HAPLO) donor cohorts and usually lack detailed information on disease evolution, coinfections, management and impact on outcomes. This study aimed to evaluate the incidence, risk factors, and outcomes in patients with hematologic malignancies undergoing HSCT from MSD, MUD, HAPLO donors using PTCy as GVHD prophylaxis. Furthermore, we analyze risk factors for BK-HC and its impact on renal function and transplant outcomes. Retrospective analysis of BK-HC episodes in patients undergoing HSCT from 167 MSD, 129 MUD and 103 HAPLO from a single institution. Uniform GVHD prophylaxis with PTCy, sirolimus and mycophenolate mofetil was given, irrespective of donor type or conditioning intensity, and mesna was used
Copyright © 2024 The American Society for Transplantation and Cellular Therapy. Published by Elsevier Inc. All rights reserved.
Datos de la publicación
- ISSN/ISSNe:
- 2666-6375, 2666-6367
- Tipo:
- Article
- Páginas:
- 1821-18211
- PubMed:
- 39701290
- Enlace a otro recurso:
- www.scopus.com
Transplantation and Cellular Therapy ELSEVIER SCIENCE INC
Citas Recibidas en Web of Science: 7
Documentos
- No hay documentos
Filiaciones
Keywords
- BK virus; Hemorrhagic Cystitis; Post-transplant; cyclophosphamide; Sirolimus; Mycophenolate mofetil
Cita
CHORA P,VILLALBA M,BALAGUER A,Montoro J,GRANADOS P,Gilabert C,Panadero F,Pardal AA,GONZÁLEZ EM,DE COSSIO S,Benavente R,GÓMEZ MD,Gómez I,SOLVES P,SANTIAGO M,ASENSI P,LLORET P,Eiris J,MARTÍNEZ D,LOURO A,REBOLLAR P,PERLA A,SALAVERT M,DE LA RUBIA J,Sanz MA,SANZ J. Incidence, Risk Factors, and Outcomes of BK Hemorrhagic Cystitis in Hematopoietic Stem Cell Transplantation From HLA-Matched and Haploidentical Donors With Post-Transplant Cyclophosphamide. Transplant. Cell. Ther. 2025. 31. (3):p. 1821-18211. IF:4,700. (1).
Portal de investigación